Charles Himmler
Family Medicine · Vilonia, ARNPI 1750349858
Payments from drug & device makers
Across 273 payments — averaging $17.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$774
- AbbVie$554
- Novo Nordisk$480
- Abbott$417
- Amgen$366
- Lilly USA, LLC$366
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,651100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $774 |
| AbbVie(2 entities) | 39 | $554 |
| Novo Nordisk | 27 | $480 |
| Abbott | 21 | $417 |
| Amgen | 18 | $366 |
| Lilly USA, LLC | 27 | $366 |
| Pfizer | 16 | $275 |
| Corium, LLC | 9 | $182 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $153 |
| GSK | 7 | $133 |
| Phathom Pharmaceuticals, Inc. | 8 | $102 |
| Dexcom, Inc. | 4 | $84 |
| Boehringer Ingelheim | 4 | $75 |
| Exact Sciences | 4 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $58 |
| Astellas Pharma US Inc | 2 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Nestle Healthcare Nutrition Inc. | 3 | $51 |
| Novartis | 3 | $43 |
| Gilead | 1 | $42 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $35 |
| Shield Therapeutics Inc | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Antares Pharma, Inc. | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| Sumitomo Pharma America, Inc. | 2 | $19 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$4,651 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $38,975 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $35,648 |
| JanuviaSitagliptin Phosphate | 45 | $33,124 |
| RybelsusSemaglutide | 21 | $24,963 |
| XareltoRivaroxaban | 22 | $17,030 |
| JardianceEmpagliflozin | 11 | $13,096 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $12,314 |
| EliquisApixaban | 16 | $12,145 |
| InvokanaCanagliflozin | 11 | $6,260 |
| MyrbetriqMirabegron | 12 | $5,532 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $4,690 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $3,689 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 12 | $2,900 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $2,744 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,681 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $480 | $63,93959 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $133 | $44,02774 claims |
| Boehringer IngelheimJardiance | $75 | $13,09611 claims |
| PfizerEliquis | $275 | $12,14516 claims |
| Astellas Pharma US IncMyrbetriq | $56 | $5,53212 claims |
| AbbVieSynthroid | $554 | $68616 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Vilonia
- George KonisLittle Rock$26.6M
- Kevin RobertsLittle Rock$2.5M
- Derek LewisLittle Rock$1.7M
- Jodi SansonHot Springs$1.7M
- Senthil RaghavanLittle Rock$496K
- Broderick EatonWynne$442K
- Landon HumphreyConway$417K
- Vonda HouchinHarrisburg$206K
- Glenn GibbonsFort Smith$179K
- Christopher BrownJonesboro$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.